rosiglitazone has been researched along with ginsenosides in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, X; Hong, L; Jin, HH; Li, X; Liu, LP; Liu, X; Zhang, B; Zhang, QG | 1 |
1 other study(ies) available for rosiglitazone and ginsenosides
| Article | Year |
|---|---|
Ginsenoside Re prevents angiotensin II-induced gap-junction remodeling by activation of PPARĪ³ in isolated beating rat atria.
Topics: Angiotensin II; Anilides; Animals; Blotting, Western; Connexin 43; Connexins; Dose-Response Relationship, Drug; Down-Regulation; Female; Gap Junction alpha-5 Protein; Gap Junctions; Ginsenosides; Heart Atria; Male; Matrix Metalloproteinase 2; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2017 |